"Fine Tuning" Engineered T Cells May Extend Immunotherapy Approach to More Cancer Types



Engineering immune cells to have a decreased affinity for their targets on cancer cells may not weaken their efficacy but may reduce the risk of side effects.



Source link

Comments are closed.